Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, AMGEN Inc’s stock clocked out at $295.76, down -0.23% from its previous closing price of $296.45. In other words, the price has decreased by -$0.23 from its previous closing price. On the day, 1.84 million shares were traded. AMGN stock price reached its highest trading level at $299.9 during the session, while it also had its lowest trading level at $294.49.
Ratios:
To gain a deeper understanding of AMGN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.01. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 7.57 whereas as Long-Term Debt/Eq ratio is at 7.24.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 20 ’25 when Grygiel Nancy A. bought 1,267 shares for $294.32 per share.
Khosla Rachna sold 1,500 shares of AMGN for $434,520 on Jun 05 ’25. The SVP, Business Development now owns 8,162 shares after completing the transaction at $289.68 per share. On Jun 05 ’25, another insider, Khosla Rachna, who serves as the Officer of the company, bought 1,500 shares for $290.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 159225937920 and an Enterprise Value of 207401893888. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.20, and their Forward P/E ratio for the next fiscal year is 13.65. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.58 while its Price-to-Book (P/B) ratio in mrq is 21.43. Its current Enterprise Value per Revenue stands at 5.94 whereas that against EBITDA is 12.844.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.48, which has changed by -0.100486636 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $339.17, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is 0.78%, while the 200-Day Moving Average is calculated to be 2.20%.
Shares Statistics:
It appears that AMGN traded 2.41M shares on average per day over the past three months and 1891500 shares per day over the past ten days. A total of 538.30M shares are outstanding, with a floating share count of 537.30M. Insiders hold about 0.20% of the company’s shares, while institutions hold 81.60% stake in the company. Shares short for AMGN as of 1753920000 were 12519619 with a Short Ratio of 5.20, compared to 1751241600 on 14747690. Therefore, it implies a Short% of Shares Outstanding of 12519619 and a Short% of Float of 2.33.
Dividends & Splits
With its trailing 12-month dividend rate of 9.26, AMGN has a forward annual dividend rate of 9.26. Against a Trailing Annual Dividend Yield of 0.031236297The stock’s 5-year Average Dividend Yield is 3.03. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-08-22. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
The dynamic stock of AMGEN Inc (AMGN) is currently attracting attention from 24.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $5.15, with high estimates of $5.74 and low estimates of $4.83.
Analysts are recommending an EPS of between $21.62 and $20.64 for the fiscal current year, implying an average EPS of $21.07. EPS for the following year is $21.67, with 30.0 analysts recommending between $23.2 and $20.31.
Revenue Estimates
In the current quarter, 22 analysts expect revenue to total $9B. It ranges from a high estimate of $9.2B to a low estimate of $8.78B. As of the current estimate, AMGEN Inc’s year-ago sales were $8.5BFor the next quarter, 22 analysts are estimating revenue of $9.37B. There is a high estimate of $9.66B for the next quarter, whereas the lowest estimate is $9.08B.
A total of 29 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.18B, while the lowest revenue estimate was $35.1B, resulting in an average revenue estimate of $35.68B. In the same quarter a year ago, actual revenue was $33.42BBased on 29 analysts’ estimates, the company’s revenue will be $36.32B in the next fiscal year. The high estimate is $37.92B and the low estimate is $34.74B.
